AM

Anurag Marutbhai Mehta

Active Director Whole-Time Director DIN 09756365
DIN 09756365 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Anurag Marutbhai Mehta

Data last updated:

Anurag Marutbhai Mehta is a Whole-Time Director at Synbiotics Limited (since 2022). The company operates in Chemicals.

DIN 09756365
Primary Designation Whole-Time Director
Industry Chemicals
First Appointment 11 Oct 2022
Oldest Company Age 66 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synbiotics Limited U24232GJ1960PLC000992
Whole-Time Director11 Oct 20221960Active

Board colleagues of Anurag Marutbhai Mehta

NameDINCompanyDesignation
Mayur Swadia01237189Synbiotics LimitedDirector
Mohal Kartikeya Sarabhai00334441Synbiotics LimitedManaging Director

Directorship timeline

Open interactive timeline →
Synbiotics Limited
Premium access

Shareholding and investment profile for Anurag Marutbhai Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Marutbhai Mehta

Anurag Marutbhai Mehta currently holds 1 directorship: Synbiotics Limited (Whole-Time Director, since 11 Oct 2022).

Anurag Marutbhai Mehta was first appointed on 11 Oct 2022 as Whole-Time Director at Synbiotics Limited.

The current boards of Anurag Marutbhai Mehta's companies include Mayur Swadia (Synbiotics Limited), Mohal Kartikeya Sarabhai (Synbiotics Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available